Steve Perrin, Ph.D., was appointed CEO and Maureen Lister was appointed president of the ALS Therapy Development Institute during the annual meeting of its board of directors. The two appointments come following the passing of Sean Scott, the Institute's previous president, due to complications from Lou Gehrig's disease this past February.
Abraxis Bioscience has named Leon O. Moulder, Jr. as vice chairman, president and CEO. Patrick Soon-Shiong, M.D., who held the positions of chairman and CEO of Abraxis BioScience since founding the company, will assume the role of executive chairman and CEO of the firm's new Abraxis Health unit.
PhotoThera has hired Arthur Taylor to serve as its president and CEO.
Azmi Nabulsi, M.D., M.P.H., was named president, Takeda Global Research & Development Center, U.S.
Zafgen has named Matthias Jaffe chief financial officer and vice president of business development.
Vertex has promoted Peter Mueller to an expanded role that covers all of its global research and development.
LifeScience Alley announced that Liz Rammer has been promoted to the role of executive vice president.
SuperGen reported that Gregory Berk, chief medical officer, has left the company.
Foley Hoag has added Lindsey Toohey to its Government Strategies Group. Toohey is the former senior health policy advisor to North Dakota Senator Kent Conrad.
CytRx announced the appointment of Jaisim Shah as chief business officer and senior vice president of business development.
WuXi PharmaTech announced that it has appointed Hao Zhou as vice president of finance.
NanoInk's NanoFabrication Systems Division announced the appointment of Tom Warwick as general manager for Europe and the Middle East.
Howard L. Levine, Ph.D., president of BioProcess Technology Consultants, has been elected to the board of directors of Protein Sciences Corporation.
DARA BioSciences named Gail F. Lieberman to its board of directors.